Table of Contents
ISRN Obstetrics and Gynecology
Volume 2014 (2014), Article ID 394595, 5 pages
Review Article

HPV Vaccination in India: Critical Appraisal

1Department of Obstetrics and Gynaecology, Hamdard Institute of Medical Sciences and Research, New Delhi 110062, India
2Reader’s Flat No. 4, Lady Hardinge Medical College Campus, New Delhi 110001, India
3Department of Obstetrics and Gynaecology, Lady Hardinge Medical College, New Delhi 110001, India
4Department of Preventive and Social Medicine, Lady Hardinge Medical College, New Delhi 110001, India

Received 3 January 2014; Accepted 3 March 2014; Published 11 March 2014

Academic Editors: M. Friedrich and J. Xercavins

Copyright © 2014 Aruna Nigam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Cervical cancer is the third most common cancer in women worldwide. The role of human papilloma virus (HPV) in the genesis of cervical carcinoma is well documented. The HPV 16 and 18 are found to be most commonly associated with invasive cervical carcinoma. The advent of cervical carcinoma vaccine has advanced the hopes that eradication of cervical carcinoma might be possible in future. The scenario of prevention of cervical carcinoma is completely different in developed and developing countries. The implementation of the vaccination as a routine in India is still controversial. Here we have tried to critically analyse these issues in Indian context. However it is clear that cervical cancer vaccine is not an immediate panacea and cannot replace the cervical cancer screening which is mandatory in Indian context.